Mastopexy with Simultaneous Renuvion Treatment, Pilot Study to Evaluate Safety.
Methods/Technique: A retrospective study was conducted on fifteen consecutive patients. Patients underwent a mastopexy augmentation with simultaneous Renuvion treatment of the breast flaps. Patients received 3 Joules of radiofrequency energy to each breast during the mastopexy. All patients had wise pattern central mound mastopexy with a dual plane breast implant placement. Patients were evaluated for any skin necrosis or wound healing issues during their postoperative period. Patients on average were followed for 109 days, with a range of 16 - 269 days.
Results/Complications: Fifteen consecutive women were included in the retrospective study. Patient evaluation for wound healing concerns showed 1/15 (7%) of patients had delayed wound healing. This patient healed with local wound care. No patients needed subsequent surgeries for wound healing concerns. Patients on average were followed for 109 days, with a range of 16 - 269 days.
Conclusion: The use of 3 joules per breast of Renuvion Radiofrequency energy was found to be safe when used simultaneously during a mastopexy surgery. This is the first step in proving long-term results of mastopexy augmentation surgeries. Future studies will evaluate the effectiveness of radiofrequency energy in long-term skin tightening of the breasts. 
